L. Saunders - Dec 29, 2021 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Yi Ching Yau, Attorney-in-Fact
Stock symbol
BBIO
Transactions as of
Dec 29, 2021
Transactions value $
$254,880
Form type
4
Date filed
1/3/2022, 06:59 PM
Previous filing
Dec 15, 2021
Next filing
Jan 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Purchase $255K +17.6K $14.48 17.6K Dec 29, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price of the shares purchased from $14.45 to $14.49 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in this footnote.